Cargando…
Xanthatin inhibits STAT3 and NF‐κB signalling by covalently binding to JAK and IKK kinases
Aberrant activation of the signal transducer and activator of transcription 3 (STAT3) and the nuclear factor‐κB (NF‐κB) signalling pathways is associated with the development of cancer and inflammatory diseases. JAKs and IKKs are the key regulators in the STAT3 and NF‐κB signalling respectively. The...
Autores principales: | Liu, Man, Xiao, Cheng‐qian, Sun, Ming‐wei, Tan, Min‐jia, Hu, Li‐hong, Yu, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533482/ https://www.ncbi.nlm.nih.gov/pubmed/30993883 http://dx.doi.org/10.1111/jcmm.14322 |
Ejemplares similares
-
Xanthatin Alleviates LPS-Induced Inflammatory Response in RAW264.7 Macrophages by Inhibiting NF-κB, MAPK and STATs Activation
por: Liu, Yuanqi, et al.
Publicado: (2022) -
Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
por: Liu, Man, et al.
Publicado: (2018) -
Inhibition of Osteoblast Functions by IKK/NF-κB in Osteoporosis
por: Chang, Jia, et al.
Publicado: (2009) -
Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells
por: Zhang, Jian, et al.
Publicado: (2021) -
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation
por: Zhao, Jing, et al.
Publicado: (2018)